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A B S T R A C T
A growing body of evidence suggests that elevated levels of reactive oxygen species (ROS) in the airways caused
by exposure to gas phase pollutants or particulate matter are able to activate dendritic cells (DCs); however, the
exact mechanisms are still unclear. When present in excess, ROS can modify macromolecules including DNA.
One of the most abundant DNA base lesions is 7,8-dihydro-8-oxoguanine (8-oxoG), which is repaired by the 8-
oxoguanine DNA glycosylase 1 (OGG1)-initiated base excision repair (BER) (OGG1-BER) pathway. Studies have
also demonstrated that in addition to its role in repairing oxidized purines, OGG1 has guanine nucleotide ex-
change factor activity when bound to 8-oxoG. In the present study, we tested the hypothesis that exposure to 8-
oxoG, the specific product of OGG1-BER, induces functional changes of DCs. Supporting our hypothesis, tran-
scriptome analysis revealed that in mouse lungs, out of 95 genes associated with DCs’ function, 22 or 42 were
significantly upregulated after a single or multiple intranasal 8-oxoG challenges, respectively. In a murine model
of allergic airway inflammation, significantly increased serum levels of ovalbumin (OVA)-specific IgE antibodies
were detected in mice sensitized via nasal challenges with OVA+8-oxoG compared to those challenged with
OVA alone. Furthermore, exposure of primary human monocyte-derived DCs (moDC) to 8-oxoG base resulted in
significantly enhanced expression of cell surface molecules (CD40, CD86, CD83, HLA-DQ) and augmented the
secretion of pro-inflammatory mediators IL-6, TNF and IL-8, whereas it did not considerably influence the
production of the anti-inflammatory cytokine IL-10. The stimulatory effects of 8-oxoG on human moDCs were
abolished upon siRNA-mediated OGG1 depletion. Collectively, these data suggest that OGG1-BER-generated 8-
oxoG base-driven cell signaling activates DCs, which may contribute to initiation of both the innate and adaptive
immune responses under conditions of oxidative stress.
1. Introduction
The lungs are constantly exposed to a large number of environ-
mental stimuli including various antigens and compounds with oxida-
tive potential. Dendritic cells (DCs), forming a network beneath the
airway epithelium, continuously monitor the inhaled materials to sense
potentially harmful microbes and substances. When DCs detect danger
and/or damage signals during internalization of foreign or self-anti-
gens, they become activated, release pro-inflammatory cytokines and
chemokines, migrate to the draining lymph nodes, where they present
antigen to naïve T lymphocytes and thus initiate adaptive immune re-
sponses [1]. An increasing body of evidence suggests that reactive
oxygen species (ROS) in the airways induced by exposure to gas phase
pollutants such as ozone [2] and nitrogen oxides [3], or to pollens [4,5]
and particulate matters [6] are all able to activate DCs; however, the
exact mechanisms still need to be defined.
Increased levels of ROS can damage all types of biological macro-
molecules, i.e., proteins, lipids, and even DNA [7]. The primary target
of free-radicals in the DNA is guanine, due to its lowest oxidation po-
tential among the DNA bases, and several oxidation products can be
https://doi.org/10.1016/j.freeradbiomed.2019.08.010
Received 10 June 2019; Received in revised form 7 August 2019; Accepted 9 August 2019
Abbreviations: 7-AAD, 7-aminoactinomycin-D; 8-oxoG, 7,8-dihydro-8-oxoguanine; BER, base excision repair; DCs, dendritic cells; moDCs, monocyte-derived DCs;
MyD88, myeloid differentiation primary response 88; OGG1, 8-oxoguanine DNA glycosylase 1; OGG1-BER, OGG1-initiated BER; OVA, ovalbumin; ROS, reactive
oxygen species; Tfh, follicular helper T cells; TLR, Toll-like receptor
∗ Corresponding author.
E-mail address: bacsi.attila@gmail.com (A. Bácsi).
1 These authors contributed equally to this work.
Free Radical Biology and Medicine 143 (2019) 209–220
Available online 10 August 2019
0891-5849/ © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
formed from it [8,9]. Among these oxidation products 7,8-dihydro-8-
oxoguanine (8-oxoG) is the most abundant and its accumulation in DNA
is considered to be one of the best biomarkers of oxidative stress [10]. If
8-oxoG is present in the DNA and encountered by the DNA replication
machinery, adenine can be misincorporated into the newly synthesized
DNA strand; therefore, 8-oxoG is considered as a mutagenic base lesion
[11]. To prevent its accumulation and mutagenic effects, the in-
trahelical 8-oxoG is recognized and excised primarily by 8-oxoguanine
DNA glycosylase 1 (OGG1) during base excision repair (BER) processes
[12,13].
In a recent series of publications we have shown that the release of
the 8-oxoG base from DNA, and its binding to cytosolic OGG1 mediates
the activation of small GTPases, including K-Ras [14,15], Rac1 [16] and
RhoA [17], and subsequent downstream signaling molecules
[15,18,19]. Furthermore, OGG1 has also been shown to bind 8-oxoG
lesions in promoter sites of NF-κB-activated genes, thus facilitating
rapid transcriptional responses following oxidative stress [19]. In ad-
dition, it has recently been demonstrated that OGG1-initiated BER
(OGG1-BER) mimicked by a single 8-oxoG challenge increases gene
expression involved in homeostatic, immune system-related, and mac-
rophage activation processes mediated by chemokines, cytokines, in-
tegrin and interleukin signaling pathways [20]. On the other hand,
ongoing OGG1-BER during intermittent exposure to environmental
oxidative agents and/or during chronic inflammation induces gene
expression resulting in epithelial alterations, increased smooth muscle
mass and collagen deposits in the airways [21].
In this particular study, we tested the hypothesis that OGG1-BER
processes producing 8-oxoG can induce DCs activation. To this end, we
utilized murine models and the in vivo obtained data were supported by
in vitro studies using human monocyte-derived DCs (moDC).
2. Materials and methods
2.1. Treatment of animals for transcriptome analysis
Animal experiments were performed according to the NIH Guide for
Care and Use of Experimental Animals and approved by the UTMB
Animal Care and Use Committee (approval no. 0807044A). Eight-week-
old female BALB/c mice (The Jackson Laboratory, Bar Harbor, ME,
USA) were used for these studies. Mice (n=5 per group) were chal-
lenged intranasally (i.n.) on day 0 (single challenge) or days 0, 2 and 4
(multiple challenge) with 60 μL of pH-balanced 8-oxoG (Cayman
Chemicals, Ann Arbor, MI, USA) solution (pH: 7.4; 1 μM), or saline
under mild anesthesia [14]. The lipopolysaccharide concentration was
below detectable levels in all reagents. Animals were sacrificed at
various time points (0, 30, 60 and 120min) after a single or multiple
challenges to isolate lung RNA as previously described [20,21].
2.2. RNA isolation
After intranasal challenge, mouse lungs were excised and homo-
genized in lysis buffer (Qiagen, Valencia, CA, USA) with a TissueMiser®
(Fisher, Pittsburgh, PA, USA). RNA was extracted using an RNeasy kit
(Qiagen) as previously described [20,21]. The RNA concentration was
determined spectrophotometrically on an Epoch Take-3™ system
(BioTek, Winooski, VT, USA) using Gen5 version 2.01 software. Equal
amounts of RNA from each mouse lung within an experimental group
(n=5) were pooled and analyzed in triplicate.
2.3. Next-generation RNA sequencing
Library construction and deep sequencing analysis were performed
in UTMB’s Next- Generation Sequencing (NGS) Core Facility (Director:
Dr. Thomas G. Wood) on an Illumina HiSeq 1000 sequencing system
(Illumina Inc., San Diego, CA, USA) as previously described [20,21].
Briefly, poly(A)+ RNA was selected from total RNA (1 μg) with poly(T)
oligo-attached magnetic beads. Bound RNA was fragmented by in-
cubation at 94 °C for 8min in 19.5 μl of fragmentation buffer (Illumina,
Part # 15016648). First- and second-strand synthesis, adapter ligation,
and amplification of the library were performed using the Illumina
TruSeq RNA Sample Preparation kit per the manufacturer’s instruc-
tions. Samples were tracked through the “index tags” incorporated into
the adapters. Library quality was evaluated using an Agilent DNA-1000
chip on an Agilent 2100 Bioanalyzer. Library DNA templates were
quantitated by qPCR and a known-size reference standard.
Cluster formation of the library DNA templates was performed using
the TruSeq PE Cluster Kit version 3 (Illumina) and the Illumina cBot
workstation under the conditions recommended by the manufacturer.
Template input was adjusted to obtain a cluster density of 700–1000 K/
mm2. Paired-end, 50-base sequencing-by-synthesis was performed with
a TruSeq SBS kit version 3 (Illumina) on an Illumina HiSeq 1000 per the
manufacturer’s protocols. Base calls were converted to sequence reads
using CASAVA-1.8.2. Sequence data were analyzed with the Bowtie2,
Tophat and Cufflinks programs using the National Center for
Biotechnology Information’s (NCBI’s) mouse (Mus musculus) genome
build reference mm10. RNA-Seq data have been deposited in the NCBI’s
Gene Expression Omnibus (GEO) and are accessible through GEO Series
accession numbers GSE61095 and GSE65031. Reads per kilobase of
transcript per million (RPKM) were normalized to the corresponding
control for each experimental group [22].
To confirm transcript levels for selected genes, an SAB biosciences
RT Profiler PCR Array assay (PAMM-090A, Qiagen) was used per the
manufacturer's instructions, using SYBR®Green. qRT-PCR was per-
formed on an ABI7000 Sequence Detector (Life Technologies, Grand
Island, NY). Quantification of changes in gene expression was calcu-
lated by using the ΔΔCt method and unstimulated cells as the calibrator
and then normalized to GAPDH [23].
2.4. Gene ontology analysis
Heat maps and hierarchical clusters from whole transcriptomes
were constructed with Morpheus online software from Broad Institute
(https://software.broadinstitute.org/morpheus). Venn diagrams were
constructed using online Venny 2.1 software (http://bioinfogp.cnb.csic.
es/tools/venny/index.html). To create a list of genes that are docu-
mented to be linked to activation of murine DCs a gene ontology
browser at the Mouse Genome Informatics website (MGI, The Jackson
Laboratory, Bar Harbor, Maine, http://www.informatics.jax.org/
vocab/gene_ontology/) and the gene list of the Mouse Dendritic and
Antigen Presenting Cell RT2 Profiler PCR Array (Qiagen) were utilized.
2.5. Treatment of animals for the measurement of IgM and IgE production
Eight-week-old female BALB/c mice (n= 8 per group) were chal-
lenged intranasally with 8 μg/mouse ovalbumin (OVA, Grade V, A5503,
Sigma–Aldrich, St. Louis, MO, USA) alone or in combination with 60 μL
of 1 μM pH-balanced 8-oxoG solution on days 0–4, 18 and 28 under
mild anesthesia. In controls, intranasal challenges were performed with
60 μL of PBS. On day 30, animals were sacrificed and sera were col-
lected for the measurement of IgM or IgE production. The levels of
OVA-specific IgM and IgE in the mice’ sera were measured by ELISA kit
(Southern Biotech, Birmingham, AL, USA), according to the manu-
facturer’s instructions. Absorbance was detected by a Synergy HT mi-
croplate reader (Bio-Tek Instruments, Winooski, VT, USA) at 450 nm.
2.6. Generation and treatment of moDCs
Leukocyte-enriched buffy coats were obtained from healthy blood
donors drawn at the Regional Blood Center of the Hungarian National
Blood Transfusion Service (Debrecen, Hungary) in accordance with the
written approval of the Director of the National Blood Transfusion
Service and the Regional and Institutional Ethics Committee of the
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University of Debrecen (Hungary). Peripheral blood mononuclear cells
(PBMCs) were isolated by centrifugation on a Ficoll-Paque (GE
Healthcare, Uppsala, Sweden) density gradient, and monocytes were
separated from PBMCs by positive selection using magnetic anti-CD14
microbeads (Miltenyi Biotec, Bergisch-Gladbach, Germany), according
to the manufacturer's instructions. For gene silencing experiments
freshly isolated monocytes were electroporated as described below. For
DC differentiation electroporated and non-electroporated monocytes
were cultured in 24-well tissue culture plates at a density of
1× 106 cells/ml in RPMI-1640 medium (Sigma–Aldrich, St. Louis, MO,
USA), supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin
(Biosera Ltd, Ringmer, UK), 10% heat-inactivated fetal bovine serum
(FBS; Gibco BRL, Grand Island, NY, USA), 80 ng/ml granulocyte–ma-
crophage colony-stimulating factor (GM-CSF; Peprotech EC, London),
and 100 ng/ml IL-4 (Peprotech EC, London, UK). On day 2, the same
amounts of GM-CSF and IL-4 were added to the cell cultures. The
moDCs were challenged at day 5 of culturing for 24 h with increasing
concentration of 8-oxoG (1, 10 or 100 μM), Toll-like receptor (TLR) 7/8
ligand CL075 (0.5 μg/ml, InvivoGen, San Diego, CA, USA) or TLR9
agonist CpG-B (5 μM, ODN2006; Hycult Biotech, Uden, The
Netherlands). To inhibit myeloid differentiation primary response 88
(MyD88)-dependent pathways, cells were pre-incubated with the
MyD88 inhibitory peptide (40 μM, Pepinh-MYD, InvivoGen) or its ne-
gative control peptide (40 μM, Pepinh-Control, InvivoGen) for 6 h and
then exposed to 8-oxoG base or TLR agonists for an additional 24 h.
During incubation periods cells were maintained at 37 °C in a humidi-
fied CO2 incubator.
2.7. Depletion of OGG1 expression
Freshly isolated monocytes were electroporated with 3 μM
siGENOME Smartpool OGG1-specific or siGENOME non-targeting small
interfering RNA (siRNA; Dharmacon, Pittsburg, PA, USA) in Opti-MEM
medium (Life Technologies) in 4-mm cuvettes (Bio-Rad Laboratories
GmbH, Munich, Germany) using GenePulser Xcell instrument (Bio-
Rad). Following transfection the cells were seeded as described above.
During DC differentiation IL-4 and GM-CSF were replenished on day 2.
On day 5, depletion of OGG1 was determined by western blotting.
2.8. Western blot analysis
Cells were lysed in Laemmli buffer and the protein samples were
separated on SDS–PAGE gels, and transferred onto nitrocellulose
membranes using wet electro-blotting. Nonspecific binding was blocked
by TBS-Tween containing 5% non-fat dry milk for 1 h at room tem-
perature and probed with antibody recognizing OGG1 (rabbit mono-
clonal; Abcam, Cambridge, UK) overnight at 4 °C. Primary antibody was
detected using horseradish peroxidase-conjugated secondary antibody
(anti-rabbit; Bio-Rad Laboratories, Munich, Germany) for 1 h at room
temperature. Anti-β-actin was used as a loading control (mouse
monoclonal; Santa-Cruz Biotechnology, Santa Cruz, CA, USA). Protein
samples were visualized by ECL system (SuperSignal West Pico/Femto
chemiluminescent substrate; Thermo Scientific, Rockford, IL, USA). The
protein bands were scanned, and band density was determined using
Kodak 1D Image Analysis software, version 3.6 (Kodak Digital Science
Imaging, Eastman Kodak, New Haven, CT, USA). Relative density was
calculated by the ratio of OGG1 versus β-actin band intensities.
2.9. Flow cytometric analysis
Cell surface protein expression was analyzed by staining the cells
with FITC-labeled monoclonal antibodies against CD40 and CD209, PE-
labeled anti-CD14, anti-CD86 and anti-HLA-DQ, PE-Cy5-labeled anti-
CD83 and APC-conjugated anti-CD1a and isotype-matched control an-
tibodies. All of the monoclonal antibodies and the isotype-matched
control antibodies were obtained from BioLegend (San Diego, CA,
USA). Fluorescence intensities were measured by FACSCalibur flow
cytometer (BD Biosciences Immunocytometry Systems, Franklin Lakes,
NJ, USA). In all flow cytometric measurements isotype-matched control
antibodies were used to detect non-specific background signals ac-
cording to the manufacturer’s recommendation. Relative fluorescence
intensity values were calculated as a ratio of median fluorescence in-
tensity of specific to non-specific isotype-matched antibodies. Data
analysis was performed by FlowJo software (TreeStar, Ashland, OR,
USA). Cell viability was determined by 7-aminoactinomycin-D (7-AAD;
10 μg/ml; Sigma-Aldrich) staining for 15min immediately before flow
cytometric analysis.
2.10. Measurement of cytokine and chemokine secretion of moDCs
Human ELISA kits (BD OptEIA; BD Biosciences, San Diego, CA, USA)
were used to quantify IL-6, TNF, IL-10 cytokines, as well as IL-8 che-
mokine in moDC supernatants. Assays were performed according to the
manufacturer׳s instructions. Absorbance measurements were performed
using a Synergy HT microplate reader (Bio-Tek Instruments) at 450 nm.
2.11. Detection of intracellular ROS levels in moDCs
Five-day human moDCs were collected and washed with warm PBS
and loaded with 50 μM 2′,7′-dihydrodichlorofluorescein diacetate
(H2DCF-DA; Invitrogen, Carlsbad, CA, USA) at 37 °C for 20min. After
removing the excess of fluorescent dye by repeated washing steps, cells
were plated in 96-well black polystyrene plate at a density of
2×105 cells/200 μl in complete RPMI 1640 medium (Sigma-Aldrich).
Cells were then exposed to increasing concentrations of 8-oxoG (1, 10
or 100 μM) or 100 μMH2O2 (as a positive control) and changes in DCF
fluorescence intensity were detected in every 15min at 530 nm by a
Synergy HT microplate reader (Bio-Tek Instruments).
2.12. DNA extraction from moDCs for the detection of its 8-oxoG content
DNA was extracted from human moDCs treated with 8-oxoG (10
and 100 μM) or H2O2 (5mM) for 1 h by salting out method as pre-
viously described [24] with some modifications. Briefly, a total of
2×106 cells were collected and washed with warm PBS. After washing
step cells were resuspended in 250 μl of TNES buffer (10mM Tris pH:
7.5, 400mM NaCl, 100mM EDTA pH: 8, 0.6% SDS) and mixed with 4 μl
of proteinase K (Sigma-Aldrich). The mixture was kept in water bath at
56 C° for 1 h. After incubation 85 μl of 6M NaCl was added and mixed
vigorously. Samples were centrifuged at 15000 g for 15min at 4 C° and
then supernatants were collected in new Eppendorf tubes. Equal vo-
lume of cold absolute ethanol was added, mixed, and the tubes were
kept at 4 °C for 10min. The precipitated DNA was centrifuged at
15000 g for 10min at 4 °C and the pellet was washed 2 times with 70%
ethanol and allowed to air dry. The DNA was dissolved in 20 μl of TE
buffer (Life Technologies Corporation) and used for dot blot experi-
ments. The concentration and purity of isolated DNA were determined
by NanoDrop spectrophotometer (Thermo Scientific, Rockford, IL,
USA).
2.13. Dot blot analysis
To determine the 8-oxoG content in DNA extracted from 8-oxoG-
and H2O2-treated moDCs, 2 μg of DNA was spotted onto a nitrocellulose
membrane. After 1 h drying non-specific binding sites of the membrane
were blocked for 1 h at room temperature with TBS-T buffer (50mM
Tris, 0.5M NaCl, 0.05% Tween-20, pH 7.4) containing 5% dry milk.
Following the blocking step the membrane was incubated with mouse
anti-8-oxoG monoclonal antibody (1:1000, clone 483.15,
MerkMillipore) in TBS-T buffer containing 5% dry milk for 1 h at room
temperature. After incubation the membrane was washed three times
with TBS-T buffer. As a secondary antibody anti-mouse IgG conjugated
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with horseradish peroxidase (GE Healthcare, Little Chalfont,
Buckinghamshire, UK) was used at a dilution of 1:10000. After 1 h in-
cubation and repeated washing steps blot signals were visualized by
ECL system (SuperSignal West Femto Chemiluminescent Substrate;
Thermo Fisher Scientific). Spot intensities were quantified using the
Image Studio Lite Software version 5.2 (LI-COR Biosciences, Lincoln,
Nebraska USA). After detection of 8-oxoG in DNA, the same membrane
was washed thoroughly with distilled deionized water and stained with
ethidium bromide (1:1000, Sigma-Aldrich) dissolved in 1X TAE (Tris-
acetate-EDTA) buffer for 1 h at room temperature. After rinsing the
membrane with 1X TAE buffer, ethidium bromide binding was visua-
lized and photographed under UV light in Azure c600 Imaging System
(Azure Biosystems, Dublin CA, USA).
2.14. Statistical analysis
Data analyses were performed using Student’s t-test or ANOVA,
followed by Bonferroni post hoc tests with GraphPad Prism v.6. soft-
ware (GraphPad Software Inc., La Jolla, CA, USA). Differences were
considered to be statistically significant at p<0.05.
3. Results
3.1. Intranasal exposure of mice to the OGG1-BER product 8-oxoG induces
changes in the expression of genes related to DC functions
We have recently described the effects of OGG1-BER process on
global transcriptome of murine lungs [20,21]. To mimic OGG1-medi-
ated generation of 8-oxoG in the airways, mice were challenged in-
tranasally with 8-oxoG base, the specific product of OGG1-BER [25].
Mice were either exposed to a single dose of 8-oxoG or repeatedly
challenged on days 0, 2 and 4 [20,21]. Total RNA was isolated from the
lungs harvested at 0, 30, 60 and 120min after single or third repeated
challenge on day 4, pooled and subjected to RNA sequencing (Fig. 1A).
After single challenge a total of 23,337 transcripts, while after repeated
challenges a total of 18,678 transcripts were identified (GEO Series
accession number GSE61095 as well as GSE65031) [20,21]. In this
particular study, we aimed to examine whether OGG1-BER processes
can alter the expression of genes related to the functions of lung DCs. In
order to do so, an online database (MGI) and the gene list from previous
publications were utilized to create a list of genes that are documented
to be associated with activation of murine DCs (Supplementary Table I).
This gene list was “overlaid” onto the data set from RNA sequencing of
samples collected after single and multiple 8-oxoG challenges. Clus-
tering of the selected genes (cytokines, chemokines and their receptors;
antigen uptake; antigen presentation; cell surface receptors; signal
transduction) and fold changes of gene expression levels are displayed
on a heat map (Fig. 1B) and shown in Supplementary Table II. The
number of significantly upregulated (≥2-fold) and downregulated
(≤-2-fold) genes at each time point is depicted in Fig. 1C. After a single
8-oxoG challenge altogether 22 out of 95 genes related to DC activation
and function were found to be significantly upregulated (Fig. 1B and
Supplementary Table II). Multiple challenges with 8-oxoG induced
more remarkable changes compared to a single challenge as they trig-
gered upregulation of altogether 42 out of 95 genes associated with DC
functions (Fig. 1B and Supplementary Table II). After exposure to a
single 8-oxoG dose the total number of significantly upregulated genes
did not show changes over the time, while in response to multiple ex-
posures gene expression peaked at 60min and did not exhibit further
increase at 120min (Fig. 1C). Venn diagrams display the numbers of
unique and differentially expressed overlapping genes at each time
point after 8-oxoG challenges (Fig. 1D) corresponding to the transcripts
shown in Supplementary Table II. The highest number of differentially
expressed genes was observed at 60min after multiple challenges when
significant upregulation of 22 unique genes as well as 12 overlapping
genes with the single challenge were detected (Fig. 1D). Despite the fact
that none of the selected 95 genes are exclusively expressed by mouse
lung DCs, coordinated upregulation of Il12b and several genes asso-
ciated with antigen presentation suggests that OGG1-BER-mediated
release of 8-oxoG may have an impact on DC activation.
3.2. Intranasal coadministration of OVA and the OGG1-BER product 8-
oxoG intensifies OVA-specific IgE production in mice
It has previously been demonstrated that intranasal sensitization
and challenge with OVA even in the absence of an adjuvant elicit all of
the immunologic features of IgE-mediated allergic airway inflammation
in murine lungs [26]. Thus, we used this model to investigate the im-
munomodulatory role of OGG1-driven DNA BER processes. As ex-
pected, repeated intranasal challenges of mice (Fig. 2A) with adjuvant-
free OVA induced a significant increase in the serum levels of both
OVA-specific IgM and IgE antibodies (Fig. 2B and C). Combined ad-
ministration of OVA and 8-oxoG base resulted in a slight increase in the
amount of OVA-specific IgM antibodies (Fig. 2B), whereas it triggered a
significant rise in OVA-specific IgE production (Fig. 2C). Recent ad-
vances in follicular helper T cell (Tfh) biology have revealed that an-
tigen presentation by DCs is necessary and sufficient to initiate Tfh
differentiation program (reviewed in Ref. [27]). Since Tfh cells play a
critical role in the regulation of IgE antibody production in allergic
immune responses to airborne allergens [28], our observations strongly
support the contribution of the OGG1-BER system to the activation of
DCs in murine lungs.
3.3. Exogenous 8-oxoG alters the phenotype and changes cytokine and
chemokine production of human moDCs
Results obtained from murine experiments prompted us to further
investigate the direct effects of exogenous 8-oxoG on human moDCs. To
this end, immature moDCs were treated with increasing concentrations
(1, 10, and 100 μM) of 8-oxoG, then expression of CD40 and CD86
costimulatory molecules, CD83 maturation marker, as well as HLA-DQ
antigen-presenting molecule on moDCs was analyzed by flow cytometry
(Fig. 3A–D). As we anticipated, exposure to exogenous 8-oxoG en-
hanced the expression of activation/maturation-associated cell surface
molecules; however, only the highest applied concentration of 8-oxoG
(100 μM) induced statistically significant changes in the expression of
all investigated markers (Fig. 3A–D).
To further examine the effects of exogenous 8-oxoG on the activa-
tion of human moDCs, cells were exposed to 1, 10, or 100 μM 8-oxoG
for 24 h, then levels of secreted IL-6, TNF-α and IL-10 cytokines and the
IL-8 chemokine present in cell culture supernatants were measured by
ELISA (Fig. 4A–D). Treatment of moDCs with 8-oxoG increased secre-
tion of the pro-inflammatory cytokines IL-6, TNF and the chemokine IL-
8 (Fig. 4A–C) in a concentration-dependent manner, whereas it had no
effect on production of the anti-inflammatory cytokine IL-10 (Fig. 4D).
Altogether, these data suggest that exogenous 8-oxoG alone is able to
induce the activation and maturation of human moDCs via increasing
the expression of antigen presenting and costimulatory molecules on
their surface, and enhancing their pro-inflammatory and chemotactic
factor production.
Several guanosine derivatives, which are structurally related to 8-
oxoG, as well as oligodeoxynucleotides containing 8-oxoG have been
reported to be potent immunostimulatory agents and induce activation
of immune cells in a TLR7-, TLR7/8- or TLR9-dependent manner
[29–32]. Therefore, we tested the involvement of these endosomal TLRs
in the exogenous 8-oxoG-triggered activation of moDCs. Inhibition of
MyD88 adaptor protein-mediated signaling cascades with Pepinh-MYD,
a blocker of MyD88 homodimerization [33], did not influence either
the 8-oxoG-induced expression of CD86 and CD83 (Supplementary
Figs. 1A and B) or the production of IL-6 and IL-8 by moDCs
(Supplementary Figs. 1C and D). In control experiments, inhibition of
MyD88 significantly blocked the CL075- (a TLR7/8 ligand) or CpG-B- (a
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TLR9 agonist) initiated activation of the cells (Supplementary
Figs. 1A–D). These results indicate that endosomal TLRs are not in-
volved in the recognition of exogenous 8-oxoG base and thus in the
induction of moDC activation.
3.4. Expression of OGG1 is required for 8-oxoG-induced activation of
human moDCs
To confirm the involvement of OGG1 in the 8-oxoG-induced phe-
notypic and functional changes of human moDCs, the expression of
OGG1 was downregulated by specific siRNA-mediated silencing. The
efficacy of OGG1 depletion was verified by western blot analysis
(Fig. 5A and B). We found that OGG1-specific siRNA downregulated the
protein level of OGG1 by ∼80% compared to the untreated or negative
control siRNA-treated moDCs (Fig. 5B). In addition, the percentage of 7-
AAD negative, viable cells were nearly 100% in all samples treated with
negative control or OGG1-specific siRNAs, indicating that siRNA
treatments did not influence the viability of the cells (Fig. 5C). Fur-
thermore, on day 5 of differentiation, immature OGG1-silenced moDCs
displayed normal DC phenotype showing low CD14 and high CD209
and CD1a levels (Fig. 5D and E) similar to non-silenced cells. In
addition, neither the baseline expression of the main activation markers
such as CD86 and CD83 (Fig. 6A and B) nor the baseline production of
IL-6 and IL-8 proinflammatory mediators (Fig. 6C) were influenced by
OGG1 depletion. These data demonstrate that OGG1 silencing does not
interfere with the differentiation and maturation processes in moDCs.
Next, we analyzed whether the 8-oxoG triggered signaling was
OGG1-dependent. To this end, OGG1-depleted moDCs were exposed to
8-oxoG at various concentrations (10 μM and 100 μM) which con-
sistently upregulated the expression of the tested cell surface markers
and increased the production of cytokines in the previous set of ex-
periments (Figs. 3 and 4). Strikingly, as shown in Fig. 7, OGG1 silencing
abrogated the 8-oxoG-induced increase in the expression of CD86
(Fig. 7A) and CD83 (Fig. 7B) as well as in the secretion of IL-6 cytokine
(Fig. 7C) and IL-8 chemokine (Fig. 7D) as compared to the negative
control siRNA-transfected cells. These findings underpin our hypothesis
that free 8-oxoG bases can activate human DCs in an OGG1-dependent
manner.
Under oxidative stress conditions nonproductive binding of OGG1
to 8-oxoG in promoter sequences could be an epigenetic mechanism to
augment the expression of proinflammatory genes [19]. Based on this
previous observation we tested whether OGG1 depletion renders
Fig. 1. Gene expression changes induced by the OGG1-BER product 8-oxoG are associated with DC activation in mice. Eight-week-old female BALB/c mice
(n=5 per group) were exposed to a single intranasal dose of OGG1-BER product 8-oxoG base (on day 0) or repeatedly challenged with it on days 0, 2 and 4. Lungs
were harvested 0, 30, 60 and 120min after the single challenge or the last challenge on day 4. Total RNA was subjected to RNA-Seq analysis as previously described
[20,21]. Schematic representation of the experimental design is shown in panel (A). (B) The clustering of the selected genes associated with “DC activation” is
demonstrated on heat map. (C) The diagram indicates the number of significantly upregulated (≥2-fold) or downregulated (≤-2-fold) genes after single or repeated
(multiple) 8-oxoG challenges. (D) Venn diagrams show the numbers of unique and overlapping transcripts altered by single or multiple 8-oxoG challenges linked to
DC activation.
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Fig. 2. Intranasal coadministration of OVA and
8-oxoG intensifies OVA-specific IgE production
in mice. Eight-week-old female BALB/c mice (n=8
per group) were challenged intranasally with OVA
alone or in combination with 1 μM 8-oxoG solution
on days 0–4, 18 and 28 under mild anesthesia as
indicated on the timeline of the experiments (A). On
day 30, animals were sacrificed and sera were col-
lected for measuring OVA-specific IgM (B) or IgE (C)
levels by ELISA. Data are presented as means ± SD
of three independent experiments and analyzed by
one-way ANOVA followed by Bonferroni's post-hoc
test. *p<0.05, ****P<0.0001 vs PBS and #p<0.05
vs. OVA.
Fig. 3. 8-OxoG treatment induces phenotypic
changes of moDCs. Human moDCs were exposed to
increasing concentrations (1, 10 and 100 μM) of 8-
oxoG for 24 h and the expression of CD40 (A), CD86
(B), HLA-DQ (C), and CD83 (D) was determined by
flow cytometry. Relative fluorescence was calculated
using the respective isotype-matched control for
each monoclonal antibody. Data are presented as
means ± SD of four independent experiments and
analyzed by one-way ANOVA followed by
Bonferroni's test as post-hoc. *P<0.05, **P<0.01 vs
control.
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moDCs unresponsive to 8-oxoG treatment due to the lack of OGG1-
driven transcriptional initiation. To this end, we measured the effects of
exogenous 8-oxoG on intracellular ROS levels in moDCs loaded with
redox-sensitive H2DCF-DA. No changes in DCF fluorescence intensities
were observed in 8-oxoG-exposed moDCs (Supplementary Fig. 2A).
Furthermore, we also evaluated the extent of oxidative DNA damage in
moDCs exposed to exogenous 8-oxoG using dot blot analysis. It was
found that treatment of cells with exogenous 8-oxoG did not elevate 8-
oxoG formation in DNA (Supplementary Fig. 2B). In control experi-
ments, a significant increase both in intracellular DCF signals and in 8-
oxoG content in DNA was detected in H2O2-treated moDCs as compared
to untreated ones (Supplementary Figs. 2A and B). These data together
indicate that exposure to exogenous 8-oxoG does not induce oxidative
stress in human moDCs or formation of 8-oxoG in DNA; therefore, it
does not trigger OGG1 binding to promoter sequences to facilitate the
recruitment of site-specific transcription factors.
4. Discussion
As sentinels of the immune system, DCs constantly sample their
microenvironment providing a crucial first line of cellular immune
defense in the peripheral tissues. They capture, process and present
antigens, and then migrate to secondary lymphoid organs where they
interact with cognate naïve T cell clones to initiate their activation.
Therefore, DCs play an essential role in linking innate and adaptive
immune responses. Immature DCs respond to a broad spectrum of en-
vironmental danger or endogenous damage signals by extensive dif-
ferentiation or maturation [34]. In reply to external or internal stimuli,
DCs, along with other cells, orchestrate an inflammatory response. A
plethora of molecules released from different cellular compartments or
organelles by either living cells under stress conditions or from dying
cells act as endogenous damage signals (reviewed in Ref. [35]). Several
lines of evidence indicate that exposure of the lung to environmental
oxidants (e.g., various gases, smoke, fine particles, chemicals) increase
8-oxoG levels in the DNA of lung resident and even in peripheral blood
cells, as well as the exogenomic 8-oxoG levels in body fluids (e.g.,
serum, urine, sputum, bronchoalveolar lavage fluid) (reviewed in Ref.
[36]). Recently, we have demonstrated that extracellular mitochondrial
DNA with higher 8-oxoG content has a potent immunostimulatory ca-
pacity on a special subset of DCs [31]. In this work we examined
whether free 8-oxoG base, the product of OGG1-BER, exerts an im-
munomodulatory effect on DCs.
In our previous studies, effects of OGG1-BER were examined by
genome-wide analysis of the mouse lung transcriptome. Mouse lungs
were challenged with free 8-oxoG base and gene expression changes
were assessed by next generation RNA-sequencing [20,21]. Tran-
scriptome analysis revealed that both single and multiple challenges
with free 8-oxoG base upregulate mRNAs associated with various bio-
logical processes including homeostasis, immune system, macrophage
activation, responses to stimulus and metabolism [20,21]. Among the
immune system processes inflammation was represented by increased
expression levels of chemokines/cytokines, interleukins and various
signaling molecules upon 8-oxoG challenge [20]. These previous find-
ings suggested that among the genes altered by OGG1 signaling, several
ones may affect function of DCs whose activation might contribute to
oxidative stress-associated inflammatory responses. Therefore, based on
online database and literature data we selected 95 genes that are pre-
viously proven to be related to DC activation and function. Our pre-
vious transcriptome analysis data were used to reveal how the expres-
sion of these 95 genes changed after a single and multiple 8-oxoG
challenges. We found that a relatively small fraction of these selected
genes associated with DC function (22 out of 95) was upregulated after
a single challenge. However, this is not surprising given the fact that
pulmonary DCs are sparsely distributed in the airways, representing
around 1% of all cells in the epithelium [37]. Despite this limitation,
our analysis revealed that 8-oxoG base increased expression of many
genes linked to DC functions in innate and adaptive immune responses.
For example, both single and multiple challenges with 8-oxoG
Fig. 4. Exogenous 8-oxoG augments the cytokine
and chemokine secretion of moDCs. Human
moDCs were treated with an increasing amount (1,
10 and 100 μM) of 8-oxoG for 24 h, then the con-
centration of released IL-6 (A), IL-8 (B), TNF (C) and
IL-10 (D) was assessed by ELISA from cell culture
supernatants. Data are presented as means ± SD of
four independent experiments and analyzed by one-
way ANOVA followed by Bonferroni's test as post-
hoc. *P<0.05, **P<0.01, ***P<0.001 vs control.
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upregulated genes associated with pro-inflammatory mediators in-
cluding chemokines (Ccl3, Ccl20, Cxcl1, Cxcl2) and cytokines (Il1a,
Il1b, Il6, Tnf). The chemokines CCL3 and CCL20 regulate migration of
DCs, which upon activation mature into effective antigen presenting
cells [38].
Antigen presentation by DCs is required for the activation of naive T
lymphocytes, such as Tfh cells which then initiate the differentiation of
B cells into antibody-producing plasma cells and promote class
switching [39]. In our experiments, due to the limiting number of lung
DCs, we assessed the adaptive immune system activating capacity of 8-
oxoG-exposed DCs in an indirect manner by measuring serum levels of
allergen-induced specific immunoglobulins, the production of which
are associated with DC activation. To this end, we utilized an adjuvant-
free OVA model of experimental allergic airway inflammation. A large
body of evidence suggests that non-adjuvant-aided respiratory exposure
of naive rodents to inert antigen is likely to result in inhalation toler-
ance. However, several reports of successful sensitization to inhaled
OVA are published in the literature (reviewed in Ref. [40]). The en-
dotoxin contamination of OVA applied in these studies may be involved
in the abrogation of inhalation tolerance. Indeed, mice lacking the LPS
receptor appeared unable to develop Th2 responses in the absence of
alum adjuvant [41]. In good agreement with these observations, crude
OVA (A5503, Sigma-Aldrich), which induced marked OVA-specific
antibody responses in our experiments, was also shown to contain a
trace amount of endotoxin (52 EU/mg, based on the Limulus amebocyte
lysate assay [42]). We have found that co-administration of 8-oxoG
base with OVA significantly increased the OVA-specific IgE production
in mice. In a recent study, the authors have elegantly demonstrated that
Fig. 5. Downregulation of OGG1 expression does
not alter the viability and the differentiation
processes of moDCs. Freshly isolated human
monocytes (day 0) were electroporated with OGG1-
specific or non-targeting (control) siRNA. (A) At day
5, depletion of OGG1 in moDCs was verified by
western blotting. Representative blots from four in-
dependent experiments are shown. (B) The bar graph
indicates silencing efficiency of OGG1 as compared
with negative control siRNA, which is taken as
100%. The means ± SD of four independent ex-
periments are shown. The cell viability (C) and the
expression level of CD14, CD209 and CD1a (D and E)
cell surface proteins were analyzed by flow cyto-
metry. Representative histograms from 4 in-
dependent experiments are shown in panel (D),
whereas bar graphs represent the means ± SD of
four individual experiments in (C) and (E). Data were
analyzed using one-way ANOVA followed by
Bonferroni’s post-hoc test. **p<0.01 vs control
siRNA.
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Tfh cells are essential for the production of IgE antibodies in immune
responses to inhaled allergens [28]. In adoptive transfer models, Th2
and Tfh cells were isolated from mice previously exposed to OVA plus
IL-33 and transferred intravenously to naive T cell-deficient (Tcrb−/−)
or IL-7 receptor α chain-deficient (Il7r−/−) mice. Furthermore, OVA
plus IL-33-exposed IL-4-IRES-eGFP (4get) reporter mice were chal-
lenged intranasally with OVA to identify the anatomic location of Th2
and Tfh cells during type 2 immune responses. Results from these ex-
periments indicated that Th2 cells were mobile and mediated type 2
cytokine production and inflammation in the airways; whereas, Tfh
cells remained in the draining lymph nodes and contributed to the
sustained IgE production by plasma cells [28]. In another study using
mice in which MHC class II expression was restricted to conventional
DCs and absent from B cells, the initial steps of Tfh differentiation,
including turning on the ability of CD4+ T cells to express Bcl6 and
CXCR5 and homing to B-cell follicles were found to require cognate-
interactions with DCs [43]. From another point of view, it has been
shown that inhalation of diesel exhaust particles (DEPs) leads to for-
mation of oxidatively modified guanine bases in DNA both in mouse
[44] and human lungs [45]. However, exposure to DEPs can not only
trigger OGG1-BER mechanism but also promote IgE responses to
neoantigens [46]. Indeed, after challenge with the neoantigen (keyhole
limpet haemocyanin) alone, neoantigen-specific IgE antibodies could
not be detected. In contrast, when co-challenge with neoantigen and
DEPs was performed, most of the subjects produced anti-neoantigen IgE
[46]. The ability of DEPs to induce a primary IgE response to subse-
quently encountered antigen can be inhibited by thiol antioxidants [47]
and induction of phase II antioxidant enzymes [48]. These previous
findings, together with our current observations provide indirect evi-
dence for the existence of a link between OGG1-BER and DC activation
in the lungs.
To underpin our findings in animal experiments in a relevant in vitro
human model, we treated human moDCs with free 8-oxoG. We found
that 8-oxoG exposure alone was able to activate human moDCs that was
reflected in the increased cell surface expression of maturation/costi-
mulatory/antigen-presenting molecules and enhanced production of
pro-inflammatory cytokines. On the contrary, we could not detect any
changes in the secretion of IL-10 upon 8-oxoG treatment suggesting that
the DC-mediated anti-inflammatory responses are not affected.
Previous studies have revealed that several guanosine derivatives,
structurally related to 8-oxoG, and oligodeoxynucleotides containing 8-
oxoG can be recognized by TLR7, TLR7/8 or TLR9, leading to activation
of immune cells [29–32]. All of these endosomal TLRs utilize MyD88
adaptor protein to initiate downstream signaling cascades [49].
Blocking of TLR-mediated signals with a MyD88-specific inhibitory
peptide (Pepinh-MYD) did not affect the 8-oxoG-induced activation of
moDCs, which excludes the involvement of endosomal TLRs in 8-oxoG-
triggered moDC activation. Based on this observations and prior find-
ings we suppose that 8-oxoG-triggered DC activation occurs via OGG1-
initiated activation of small GTPases. We have previously shown that 8-
oxoG base in complex with OGG1 induces the activation of small
GTPases triggering multiple cellular signal transduction pathways
[14,16,18]. Small GTPases are also involved in the regulation of DC
functions including differentiation [50,51], endocytosis [52], matura-
tion [53,54], chemotaxis [52], antigen presentation [52], cross-pre-
sentation [55–57] and T cell priming [58]. All these observations imply
that human DCs exhibit the molecular signaling network, which can
mediate the 8-oxoG:OGG1 complex-triggered inflammatory responses.
Furthermore, it has been found that small GTPases can play a positive
or negative regulatory role in NF-κB activation depending on the cel-
lular context [59]. A growing body of evidences has revealed that small
GTPases such as Rac1, RhoG regulate gene expression, primarily
through the initiation of MAPK, PI3K cascades, and eventually culmi-
nate in the activation of NF-κB signaling pathway [60–62]. We have
recently reported that the OGG1-BER product 8-oxoG base also acti-
vates the canonical NF-κB pathway via KRAS, PI3K, MAPK and mi-
togen-stress related kinase (MSK) and consequently increases the ex-
pression of inflammatory mediators in airway epithelial cells [15]. In
the present study we show that the 8-oxoG-triggered moDC activation is
completely abrogated by OGG1 depletion, suggesting that the presence
and functional activity of OGG1 are essential in these processes. Pre-
sumably, due to the lack of OGG1, less 8-oxoG:OGG1 complex is formed
in the cytoplasm of DCs that decreases the activation of small GTPase-
mediated signaling pathways. Another possible mechanism is that
OGG1 deficiency reduces association of NF-κB with promoter sequences
leading to decreased activation of DCs. This assumption is based on
findings that OGG1 binding to its substrate in double-stranded DNA is
able to function as an epigenetic regulator of gene expression in
Fig. 6. OGG1 silencing does not influence the maturation state of moDCs.
Freshly isolated human monocytes (day 0) were electroporated with OGG1-
specific or non-targeting (control) siRNA. At day 5 of OGG1 depletion the ex-
pression levels of CD86 and CD83 (A and B) maturation markers were assessed
by flow cytometry and the concentrations of the IL-6 pro-inflammatory cyto-
kine and IL-8 chemokine (C) were determined from cell culture supernatants by
ELISA. Representative histograms from 4 independent experiments are shown
in panel (A), whereas bar graphs represent the means± SD of four individual
experiments in (B) and (C).
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oxidatively stressed cells [63–65]. In particular, OGG1 depletion has
been found to decrease both the association of NF-κB with promoter
sequences and cellular transcriptional response to TNF exposure.
However, based on our observations that treatment of human moDCs
with exogenous 8-oxoG does not induce oxidative stress in the cells or
formation of 8-oxoG in their DNA, the potential mechanism that OGG1
binding to promoter sequences facilitates the initiation of gene ex-
pression can be ruled out. We would like to emphasize that in all of our
experiments we used freshly solubilized 8-oxoG base proven to be
oxidatively inert in various human cell cultures [66].
In conclusion, while playing an important role in maintaining
genome integrity via excising 8-oxoG from DNA, the repair enzyme
OGG1 has been associated to inflammation-related pathologies as well
[67]. For instance, OGG1 signaling exacerbates antigen-driven allergic
inflammation [68], whereas OGG1 gene polymorphisms have been re-
ported to be associated with rheumatoid arthritis progression [69]. The
results of the present study highlight for the first time the importance of
OGG1-BER mechanism in DC activation. DCs play a major role in both
initiating inflammation and linking innate and adaptive immune re-
sponses and they are the most potent targets among immune cells for
immune-based therapies [70]. Therefore, we propose that a transient
and selective modulation of OGG1 activity in DCs could decrease the
severity of inflammation-associated diseases and might have clinical
benefits.
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